1. Early Observations (1940s–1970s):

• Scientists first described Small “cell debris” or “platelet dust” from platelets.
• These early vesicles were membrane-bound and considered waste material rather than biologically active structures.

2. The Birth of the “Exosome” Concept (1980s):

• Researchers studying maturing reticulocytes (immature red blood cells) noticed that transferrin receptors were lost through the release of small vesicles.
• They identified this process as exosome secretion — small vesicles (30–150 nm) formed inside multivesicular bodies (MVBs) and released when these MVBs fused with the plasma membrane.
• This was the first clear evidence that cells actively release vesicles as part of normal physiology — not just waste.

3. Expansion of the Field (1990s–2000s)

• EVs were detected in many body fluids: blood, urine, saliva, breast milk, semen, cerebrospinal fluid, etc.
• Scientists realized they contained proteins, lipids, and nucleic acids, suggesting a potential role in intercellular communication.
• The term “extracellular vesicles (EVs)” emerged as an umbrella term including:
  • Exosomes (endosome-derived, 30–150 nm)
  • Microvesicles (directly shed from plasma membrane, 100–1000 nm)
  • Apoptotic bodies (from dying cells, >1000 nm)

4. Molecular Cargo and Communication (2000s–2010s)

• In 2007, scientists discovered that exosomes carry mRNA and microRNA that can be transferred to other cells and translated into proteins.
  • This was a landmark finding showing EVs as natural carriers of genetic information.
  • Subsequent studies confirmed EV roles in immune regulation, tumor progression, neuronal communication, and tissue repair.
• EVs became recognized as biological messengers, not just waste.

5. Standardization and Clinical Potential (2010s–Present)

• 2011: Formation of the International Society for Extracellular Vesicles (ISEV) to unify definitions and promote rigorous research standards.
• The 2013 Nobel prize covers intracellular vesicle traffic (vesicles moving inside the cell, or towards the plasma membrane, docking, fusing), the conceptual foundation of “vesicles as cargo carriers” is very relevant to EV research. Many of the molecular mechanisms underlying vesicle formation, budding, docking, and fusion are part of the “vesicle biology” theory.
• 2014: Journal of Extracellular Vesicles launched as the official ISEV publication.
• EVs are now intensely studied for:
  • Diagnostics (liquid biopsy biomarkers)
  • Therapeutics (drug, RNA, or protein delivery)
  • Regenerative medicine (stem-cell-derived exosomes for tissue repair)

6. Present & Future

• EV research now intersects with nanomedicine, regenerative therapy, and immunology.
• Stem-cell-derived EVs (especially from mesenchymal stromal cells) show promise in anti-inflammatory and tissue regeneration therapies.